Search

Search Constraints

You searched for: Author/Creator Radke, Josefine

Search Results

1. ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA. (11th November 2019)

2. Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis. Issue 3 (May 2018)

4. Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient. Issue 8 (3rd July 2021)

6. Early Loss of Pericytes and Perivascular Stromal Cell-Induced Scar Formation after Stroke. Issue 3 (March 2013)

7. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Issue 6 (1st December 2022)

8. Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH‐mutant and 1p/19q‐codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report. Issue 1 (14th December 2022)

9. Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma. Issue 2 (24th November 2020)

10. NanoString technology distinguishes anti‐TIF‐1γ+ from anti‐Mi‐2+ dermatomyositis patients. (27th May 2021)